AI assistant
Zoetis Inc. — Director's Dealing 2022
Jul 11, 2022
29945_dirs_2022-07-11_1f909cd0-ff94-4af6-ab07-b9c04f3f811a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zoetis Inc. (ZTS)
CIK: 0001555280
Period of Report: 2022-07-07
Reporting Person: PECK KRISTIN C (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-07-07 | Common Stock | M | 311 | $30.89 | Acquired | 40054 | Direct |
| 2022-07-07 | Common Stock | S | 311 | $180 | Disposed | 39743 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-07-07 | Stock Option | $ | M | 311 | Disposed | Common Stock (311.0) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021.
F2: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F3: 311 options granted March 4, 2014 at an exercise price of $30.89 per option.
F4: Each option vests on the third anniversary of the date of grant.
F5: Each option expires on the tenth anniversary of the date of grant.
F6: 4,725 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.